Stockscreener 앱 받기
2.72
30.77%
0.64
시간 외 거래:
2.94
0.22
+8.09%
전일 마감가:
$2.08
열려 있는:
$2.24
하루 거래량:
6.11M
Relative Volume:
12.81
시가총액:
$164.76M
수익:
-
순이익/손실:
$-64.86M
주가수익비율:
-2.4286
EPS:
-1.12
순현금흐름:
$-55.66M
1주 성능:
+46.24%
1개월 성능:
+28.91%
6개월 성능:
+73.25%
1년 성능:
+67.90%
1일 변동 폭
$2.23
$2.7281
1주일 범위
$1.76
$3.01
52주 변동 폭
$0.8551
$3.01
Acumen Pharmaceuticals Inc Stock (ABOS) Company Profile
명칭
Acumen Pharmaceuticals Inc
전화
617-344-4190
주소
1210-1220 WASHINGTON STREET, NEWTON
ABOS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABOS
Acumen Pharmaceuticals Inc
|
2.72 | 125.99M | 0 | -64.86M | -55.66M | -1.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Acumen Pharmaceuticals Inc Stock (ABOS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-17 | 개시 | Citigroup | Buy |
| 2024-07-26 | 개시 | Citigroup | Buy |
| 2023-12-12 | 개시 | Deutsche Bank | Buy |
| 2023-07-20 | 재개 | BofA Securities | Buy |
| 2023-05-18 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-07-15 | 개시 | BTIG Research | Buy |
| 2022-06-30 | 개시 | H.C. Wainwright | Buy |
| 2022-01-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-07-26 | 개시 | BofA Securities | Neutral |
| 2021-07-26 | 개시 | Credit Suisse | Outperform |
| 2021-07-26 | 개시 | Stifel | Buy |
| 2021-07-26 | 개시 | UBS | Buy |
모두보기
Acumen Pharmaceuticals Inc 주식(ABOS)의 최신 뉴스
Assessing Acumen Pharmaceuticals (ABOS) Valuation After New Phase 2 ALTITUDE-AD Trial Developments - Yahoo Finance
Acumen Pharmaceuticals (NASDAQ:ABOS) Price Target Raised to $7.00 at BTIG Research - MarketBeat
Baker Hughes To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga
ABOS: BTIG Raises Price Target to $7.00, Maintains Buy Rating | - GuruFocus
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Acumen Pharmaceuticals’ Share Volatility: Insight Into Recent Developments - StocksToTrade
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Does Sabirnetug’s Phase 2 Extension and Insider Stock Sales Alter the Bull Case for ABOS? - Yahoo Finance
Acumen Pharma CFO Zuga sells shares worth $7.6k By Investing.com - Investing.com Canada
Acumen Pharmaceuticals CLO sells shares worth $16,720 By Investing.com - Investing.com Nigeria
Acumen Pharmaceuticals CEO sells shares worth $21993 By Investing.com - Investing.com South Africa
Acumen Pharma CMO Siemers sells $5.8k in ABOS stock By Investing.com - Investing.com Canada
Acumen Pharmaceuticals CEO sells shares worth $21993 - Investing.com
Daniel Joseph Oconnell Sells 9,346 Shares of Acumen Pharmaceuticals (NASDAQ:ABOS) Stock - MarketBeat
Acumen Pharmaceuticals CLO sells shares worth $16,720 - Investing.com
"Study Within A Study" Reveals Best Recruitment Strategies For Alzheimer's Trials - Clinical Leader
VIX Spike: How does Acumen Pharmaceuticals Inc perform in inflationary periods2025 Technical Overview & Smart Swing Trading Techniques - baoquankhu1.vn
EV Market: What is the earnings history of Acumen Pharmaceuticals IncQuarterly Performance Summary & Low Drawdown Momentum Ideas - baoquankhu1.vn
Acumen Pharmaceuticals Inc. (ABOS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Daniel Joseph Oconnell Sells 12,941 Shares of Acumen Pharmaceuticals (NASDAQ:ABOS) Stock - Defense World
Acumen Pharma COO Barton sells $6.5k in shares By Investing.com - Investing.com UK
Meisner, Acumen Pharmaceuticals CLO, sells $91k in ABOS stock By Investing.com - Investing.com Nigeria
Acumen Pharma CEO O’Connell sells $47k in shares By Investing.com - Investing.com Canada
Acumen Pharmaceuticals (NASDAQ:ABOS) CEO Daniel Joseph Oconnell Sells 12,941 Shares - MarketBeat
Acumen Pharmaceuticals (NASDAQ:ABOS) CEO Sells $14,820.26 in Stock - MarketBeat
Insider Selling: Acumen Pharmaceuticals (NASDAQ:ABOS) CFO Sells 6,888 Shares of Stock - MarketBeat
Meisner, Acumen Pharmaceuticals CLO, sells $91k in ABOS stock - Investing.com
Acumen Pharmaceuticals, Inc Updates Corporate Presentation with New Data - TradingView
Acumen Pharmaceuticals (NASDAQ:ABOS) Insider Sells $11,769.94 in Stock - Defense World
Acumen Pharmaceuticals COO Barton Russell sells shares worth $4,692 - MSN
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Acumen Pharmaceuticals CFO sells shares totaling $56,619 - MSN
Acumen Pharma president Doherty sells $15k in ABOS stock - Investing.com
Acumen pharma chief regulatory officer sells $2k in shares By Investing.com - Investing.com South Africa
Acumen pharma chief regulatory officer sells $2k in shares - Investing.com
Acumen Pharma president Doherty sells $15k in ABOS stock By Investing.com - Investing.com UK
James Doherty Sells 6,467 Shares of Acumen Pharmaceuticals (NASDAQ:ABOS) Stock - MarketBeat
Will Acumen Pharmaceuticals Inc. stock outperform international peers2025 Trading Volume Trends & Breakout Confirmation Alerts - ulpravda.ru
Can Acumen Pharmaceuticals Inc. stock beat market expectations this quarterQuarterly Portfolio Summary & Safe Capital Growth Trade Ideas - ulpravda.ru
Will Acumen Pharmaceuticals Inc. stock outperform value stocks2025 Pullback Review & Fast Entry Momentum Alerts - Улправда
Can Acumen Pharmaceuticals Inc. stock maintain growth trajectoryMarket Volume Report & Smart Allocation Stock Tips - ulpravda.ru
Acumen Pharmaceuticals CLO sells $52,689 in shares By Investing.com - Investing.com UK
Eric Siemers Sells 6,834 Shares of Acumen Pharmaceuticals (NASDAQ:ABOS) Stock - MarketBeat
Acumen Pharmaceuticals (NASDAQ:ABOS) CFO Matt Zuga Sells 5,100 Shares - MarketBeat
Acumen Pharma CMO Siemers sells $21k in ABOS stock By Investing.com - Investing.com Canada
Acumen Pharmaceuticals CLO sells $52,689 in shares - Investing.com
Acumen Pharma CEO O’Connell sells $94k in shares By Investing.com - Investing.com Canada
Acumen Pharma CFO Zuga sells $29k in ABOS stock By Investing.com - Investing.com Canada
Acumen Pharmaceuticals, Inc.Common Stock (NQ: ABOS - FinancialContent
Is Acumen Pharmaceuticals Inc. stock supported by innovation pipelineRisk-Reward Ratio Analysis & Fast Profit Portfolio Plans - Улправда
Acumen Pharmaceuticals (NASDAQ:ABOS) CEO Daniel Joseph Oconnell Sells 5,102 Shares - MarketBeat
Acumen Pharmaceuticals Inc (ABOS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.09%
0.48%
자본화:
|
볼륨(24시간):